Delivery Order SPE2DB20D2104-SPE2DB26FMALY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,295.61 to AmerisourceBergen Drug Corp on October 21, 2025, for pharmaceutical products and medical supplies under the Pharmaceutical Prime Vendor Division. This firm fixed price delivery order, with an ultimate completion date of October 21, 2025, represents a child contract action executed against AmerisourceBergen's larger indefinite delivery vehicle with DLA. The work will be performed at the contractor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,812.14 to AmerisourceBergen Drug Corp on October 21, 2025, under the Pharmaceutical Prime Vendor Division contract. This firm fixed-price delivery order, with an ultimate completion date of October 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The award was...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,854.62 on April 19, 2025, with an ultimate completion date of April 21, 2025. This competitive, non-set-aside contract was issued by the Defense Logistics Agency's Medical Supply Chain division and represents a firm fixed-price delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The specific...
- The Defense Logistics Agency awarded a delivery order valued at $1,153.36 to AmerisourceBergen Drug Corp on October 27, 2025, under the Pharmaceutical Prime Vendor Division contract. This firm fixed-price delivery order is non-set-aside and carries an ultimate completion date of October 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this award and operates as a critical pharmaceutical distributor supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,017.14 to AmerisourceBergen Drug Corp on August 6, 2025, under a firm fixed-price contract for pharmaceutical products and medical supplies. The delivery order, issued under contract 4569211122 and designated as a Pharmaceutical PV (Prime Vendor) Division award, is non-competitive with an ultimate completion date of August 7, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work...
- The Defense Logistics Agency awarded a delivery order valued at $3,731.87 to AmerisourceBergen Drug Corp on October 27, 2025, under the Pharmaceutical PV Division contract. This firm fixed-price delivery order, with performance in Conshohocken, Pennsylvania, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively made with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,053.16 to AmerisourceBergen Drug Corp on October 20, 2025, with an ultimate completion date of October 21, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award under the Pharmaceutical Prime Vendor Global Program. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,636.04 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025. This firm fixed price delivery order, which represents a child contract under a larger indefinite delivery vehicle, is non-competitive and carries an ultimate completion date of September 11, 2025. The award leverages AmerisourceBergen's extensive federal...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,581.62 to AmerisourceBergen Drug Corp on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price delivery order, issued under the Pharmaceutical Prime Vendor Global Program vehicle, represents a child contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $387,190.90 to AmerisourceBergen Drug Corp on July 28, 2025, under a firm fixed-price contract type. The contract, which is a child order under AmerisourceBergen's larger Pharmaceutical Prime Vendor Global Program IDC, is scheduled for completion by July 29, 2025. No set-aside designation was used in this competitive award, and performance will take place at AmerisourceBergen's corporate office in...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMALYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,195.94 to AmerisourceBergen Drug Corp on October 23, 2025, under the Pharmaceutical Prime Vendor Global Program contract vehicle. This firm fixed-price delivery order, with an ultimate completion date of October 24, 2025, represents a child order against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively made with no set-aside designation and involves pharmaceutical supply delivery to the specified place of performance in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies comprehensive pharmaceutical products and medical supplies to support military healthcare systems and other government agencies, including the Defense Health Agency and U.S. Coast Guard. The company's extensive contract portfolio with DLA encompasses a broad therapeutic range, including specialty medications, brand-name and generic drugs, vaccines, medical devices, and related healthcare commodities. This delivery order exemplifies AmerisourceBergen's ongoing role in the DLA Medical Supply Chain as a prime vendor capable of fulfilling federal medical procurement requirements through open competition.